Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 2/20 | 0.33 |
| ▸ | SLC2A3 | P11169 | 2/20 | 0.33 |
| ▸ | SLC2A4 | P14672 | 2/20 | 0.33 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | UGCG | Q16739 | 2/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.30 |
| ▸ | CCR8 | P51685 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | GCK | P35557 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10136315 | 0.93 | MDM2 (0.32) | DHODHMALT1TRPV1PTK2CYP3A4 | |
| SCHEMBL10136639 | 0.93 | SLC2A1 (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2DHODH | |
| SCHEMBL10136614 | 0.91 | CRHR1 (0.39) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL10136623 | 0.86 | DHODH (0.35) | DHODHCYP3A4UGCG | |
| SCHEMBL12117374 | 0.84 | SLC2A1 (0.37) | SLC2A1SLC2A3SLC2A4SLC2A2EGLN1 | |
| SCHEMBL10136930 | 0.83 | CRHR1 (0.40) | — | |
| SCHEMBL12113192 | 0.81 | OPRL1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2KLKB1 | |
| SCHEMBL11928309 | 0.81 | SLC2A1 (0.33) | SLC2A1SLC2A3SLC2A4SLC2A2KLKB1 | |
| SCHEMBL11928505 | 0.81 | SLC2A1 (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2KLKB1 | |
| SCHEMBL12113367 | 0.81 | SLC2A1 (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582688-B1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | SLC2A1 3127/4885SLC2A3 3314/4885SLC2A4 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.